These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 2658896)
1. Staphylococcus aureus nasal carriage in hemodialysis patients. Its role in infection and approaches to prophylaxis. Chow JW; Yu VL Arch Intern Med; 1989 Jun; 149(6):1258-62. PubMed ID: 2658896 [TBL] [Abstract][Full Text] [Related]
2. Staphylococcus aureus nasal carriage and infection in patients on hemodialysis. Efficacy of antibiotic prophylaxis. Yu VL; Goetz A; Wagener M; Smith PB; Rihs JD; Hanchett J; Zuravleff JJ N Engl J Med; 1986 Jul; 315(2):91-6. PubMed ID: 3523240 [TBL] [Abstract][Full Text] [Related]
3. Staphylococcus aureus infections in haemodialysis patients: pathophysiology and use of nasal mupirocin for prevention. Boelaert JR; Van Landuyt HW; De Baere YA; Deruyter MM; Daneels RF; Schurgers ML; Matthys EG; Gordts BZ J Chemother; 1995 Jul; 7 Suppl 3():49-53. PubMed ID: 8609538 [TBL] [Abstract][Full Text] [Related]
4. Treatment of Staphylococcus aureus colonization and prophylaxis for infection with topical intranasal mupirocin: an evidence-based review. Laupland KB; Conly JM Clin Infect Dis; 2003 Oct; 37(7):933-8. PubMed ID: 13130405 [TBL] [Abstract][Full Text] [Related]
5. Nasal carriage of meticillin resistant Staphylococcus aureus: the prevalence, patients at risk and the effect of elimination on outcomes among outclinic haemodialysis patients. Lederer SR; Riedelsdorf G; Schiffl H Eur J Med Res; 2007 Jul; 12(7):284-8. PubMed ID: 17933699 [TBL] [Abstract][Full Text] [Related]
6. Oral rifampin for prevention of S. aureus carriage-related infections in patients with renal failure--a meta-analysis of randomized controlled trials. Falagas ME; Fragoulis KN; Bliziotis IA Nephrol Dial Transplant; 2006 Sep; 21(9):2536-42. PubMed ID: 16705024 [TBL] [Abstract][Full Text] [Related]
7. Nasal mupirocin ointment decreases the incidence of Staphylococcus aureus bacteraemias in haemodialysis patients. Boelaert JR; Van Landuyt HW; Godard CA; Daneels RF; Schurgers ML; Matthys EG; De Baere YA; Gheyle DW; Gordts BZ; Herwaldt LA Nephrol Dial Transplant; 1993; 8(3):235-9. PubMed ID: 8385291 [TBL] [Abstract][Full Text] [Related]
8. Frequency of nasal carriage of Staphylococcus aureus and its antimicrobial resistance pattern in patients on hemodialysis. Ghasemian R; Najafi N; Makhlough A; Khademloo M Iran J Kidney Dis; 2010 Jul; 4(3):218-22. PubMed ID: 20622310 [TBL] [Abstract][Full Text] [Related]
9. Effect of mupirocin treatment on nasal, pharyngeal, and perineal carriage of Staphylococcus aureus in healthy adults. Wertheim HF; Verveer J; Boelens HA; van Belkum A; Verbrugh HA; Vos MC Antimicrob Agents Chemother; 2005 Apr; 49(4):1465-7. PubMed ID: 15793127 [TBL] [Abstract][Full Text] [Related]
10. Lack of efficacy of mupirocin in the prevention of infections with Staphylococcus aureus in liver transplant recipients and candidates. Paterson DL; Rihs JD; Squier C; Gayowski T; Sagnimeni A; Singh N Transplantation; 2003 Jan; 75(2):194-8. PubMed ID: 12548122 [TBL] [Abstract][Full Text] [Related]
11. Nasal carriage of Staphylococcus aureus and prevention of nosocomial infections. Kluytmans JA; Wertheim HF Infection; 2005 Feb; 33(1):3-8. PubMed ID: 15750752 [TBL] [Abstract][Full Text] [Related]
12. Staphylococcus aureus infections during peritoneal dialysis. Coles GA J Chemother; 1995 Jul; 7 Suppl 3():67-70. PubMed ID: 8609540 [TBL] [Abstract][Full Text] [Related]
13. Nasal carriage of Staphylococcus aureus in families of children on peritoneal dialysis. European Pediatric Peritoneal Dialysis Study Group (EPPS). Oh J; von Baum H; Klaus G; Schaefer F Adv Perit Dial; 2000; 16():324-7. PubMed ID: 11045321 [TBL] [Abstract][Full Text] [Related]
14. Staphylococcus aureus nasal carriage in patients on haemodialysis: role of cutaneous colonization. Peña C; Fernández-Sabe N; Domínguez MA; Pujol M; Martinez-Castelao A; Ayats J; Gudiol F; Ariza J J Hosp Infect; 2004 Sep; 58(1):20-7. PubMed ID: 15350709 [TBL] [Abstract][Full Text] [Related]
15. Association between nasal methicillin-resistant Staphylococcus aureus carriage and infection in liver transplant recipients. Patel R Liver Transpl; 2001 Aug; 7(8):752-3. PubMed ID: 11780649 [No Abstract] [Full Text] [Related]
17. [Epidemiology and prevention of Staphylococcus aureus infections during hemodialysis]. Boelaert JR; Van Landuyt HW; De Baere YA; Gheyle DW; Daneels RF; Schurgers ML; Matthys EG; Gordts BZ Nephrologie; 1994; 15(2):157-61. PubMed ID: 8047204 [TBL] [Abstract][Full Text] [Related]
18. Outcome and clinical implications of a surveillance and treatment program for Staphylococcus aureus nasal carriage in peritoneal dialysis patients. Crabtree JH; Hadnott LL; Burchette RJ; Siddiqi RA Adv Perit Dial; 2000; 16():271-5. PubMed ID: 11045309 [TBL] [Abstract][Full Text] [Related]
19. Staphylococcus aureus infection in haemodialysis patients. Mupirocin as a topical strategy against nasal carriage: a review. Boelaert JR J Chemother; 1994 Apr; 6 Suppl 2():19-24. PubMed ID: 7799051 [TBL] [Abstract][Full Text] [Related]
20. Clinical and economic effects of mupirocin calcium on preventing Staphylococcus aureus infection in hemodialysis patients: a decision analysis. Bloom BS; Fendrick AM; Chernew ME; Patel P Am J Kidney Dis; 1996 May; 27(5):687-94. PubMed ID: 8629629 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]